<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-79 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-79</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-79</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-1.html">extraction-schema-1</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <p><strong>Paper ID:</strong> paper-259174588</p>
                <p><strong>Paper Title:</strong> Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer</p>
                <p><strong>Paper Abstract:</strong> The most common oncogenic driver in non-small-cell lung cancer (NSCLC) is the epidermal growth factor receptor (EGFR) gene mutations that occur more frequently among Asians (30%–50%) as opposed to Caucasians (10%–15%). Lung cancer is one of the most prevalent cancers in India, with a reported adenocarcinoma positivity ranging between 26.1% and 86.9% in NSCLC patients. The prevalence of EGFR mutations in adenocarcinoma patients (36.9%) in India is higher than that of Caucasian patients and lower than that of East Asian patients. The exon 19 deletion (Ex19del) is more common than exon 21 L858R mutations in Indian patients with NSCLC. Studies have shown that the clinical behaviour of patients with advanced NSCLC differs between EGFR Ex19del and exon 21 L858R mutation status. In this study, we investigated the differences in clinicopathological features and survival outcomes after first line and second-line treatment with EGFR tyrosine kinase inhibitors (EGFR TKIs) in NSCLC patients with Ex19del and exon 21 L858R EGFR mutation status. This study also focuses on the role and potential benefits of dacomitinib, a second-generation irreversible EGFR TKI, in patients with Ex19del and exon 21 L858R EGFR mutation-positive advanced NSCLC in Indian settings.</p>
                <p><strong>Cost:</strong> 0.018</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e79.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e79.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Asian vs Caucasian EGFR frequency</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR mutation frequency in Asian compared with Caucasian NSCLC patients</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Literature summary reported in this review that EGFR-activating mutations occur substantially more often in Asian patients than in Caucasians, with wide reported ranges across studies.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Literature summary across multiple studies (not a single cohort); aggregated statement comparing Asian and Caucasian NSCLC populations</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>East Asian (broadly) vs Caucasian/European</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Asian: 30%–50%; Caucasian: 10%–15%</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Not specified in this summary statement (sensitising mutations Ex19del and exon21 L858R constitute majority in EGFR-positive tumours)</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Direct comparison reported: Asian 30%–50% vs Caucasian 10%–15%</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Not specified in this summary; elsewhere in paper EGFR mutations associated with female sex and never-smoking</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Not explicitly discussed for this comparative statistic in the paper; potential confounders implied include differences in histology mix, testing practices and study populations</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Broad continental/regional contrast (Asia vs Europe/North America)</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer', 'publication_date_yy_mm': '2023-06'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e79.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e79.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PIONEER study (Asia)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Multinational prospective molecular epidemiology study of EGFR mutations in Asian adenocarcinoma NSCLC patients across several Asian locations; reported an overall EGFR mutation rate in adenocarcinoma patients.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Asian patients from multiple countries (China, Hong Kong, India, Philippines, Taiwan, Thailand and Vietnam); exact sample size not specified in this review's text</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Various Asian populations (multinational East and Southeast Asian representation)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Reported overall EGFR mutation rate in adenocarcinoma patient population: 26% (as stated in this review)</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Not broken down in the review's statement of PIONEER result</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Study targeted adenocarcinoma histology</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Not detailed here; as a multinational study, heterogeneity between centres could be a factor</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Multinational Asian (China, Hong Kong, India, Philippines, Taiwan, Thailand, Vietnam)</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer', 'publication_date_yy_mm': '2023-06'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e79.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e79.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>India overall EGFR prevalence (Gupta)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Systematic review / meta-analysis of EGFR-positive adenocarcinoma NSCLC prevalence in India (Gupta et al.)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A recent India-focused systematic review/meta-analysis reporting pooled EGFR prevalence and subgroup differences by sex and smoking status in Indian adenocarcinoma NSCLC.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>27 epidemiology of EGFR positive adenocarcinoma NSCLC from India: A systematic review and meta-analysis</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Patients with adenocarcinoma NSCLC from multiple Indian centres/studies aggregated in a meta-analysis; exact pooled sample size not restated in review excerpt</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Indian</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>36.9% (95% CI 33.0 to 40.8)</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Overall EGFR-positive cases include Ex19del and exon21 L858R as dominant sensitising mutations (see subtype distributions elsewhere); review states Ex19del more common than L858R in Indian reports</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td>Higher EGFR mutation positivity in non-smokers than smokers: non-smokers 40.9% vs smokers 21.4% (reported in the review citing Gupta et al.)</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Within-India pooled prevalence reported; compared elsewhere in paper to Asian and Caucasian ranges</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Higher prevalence in females than males (42.2% vs 26.5%); predominance in adenocarcinoma histology</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Regional heterogeneity within India, differences in study design and testing methods contribute to variability</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>National (India) pooled estimate; regional differences within India discussed elsewhere in review</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer', 'publication_date_yy_mm': '2023-06'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e79.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e79.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Doval et al. Indian cohort</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Clinical and Epidemiological study of EGFR mutations and Eml4-ALK fusion genes among Indian patients with adenocarcinoma of the lung</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Single/multi-centre retrospective analysis of EGFR mutation prevalence in Indian adenocarcinoma NSCLC patients reporting mutation frequency and associations with sex, smoking and metastasis sites.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Clinical and Epidemiological study of EGFR mutations and Eml4-ALK fusion genes among Indian patients with adenocarcinoma of the lung</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>500 adenocarcinoma NSCLC patients treated at 6 centres across India (retrospective analysis)</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Indian</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>33%</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Ex19del and exon21 L858R are the common sensitising mutations; paper notes Ex19del more common than L858R in Indian reports (ranges provided elsewhere)</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td>In this cohort exon 21 L858R point mutations were predominant in males; Ex19del significantly correlated with female gender and non-smokers (p<0.05)</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Compared regional/sex/smoking subgroups within the Indian cohort; not a direct cross-ethnic comparison</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Majority (74%) presented with advanced-stage disease; common metastasis sites bone (42.6%), brain (22.8%), liver (13.8%), adrenal (9.6%); Ex19del correlated with pleural effusion and distant metastases</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Study is retrospective; high proportion with advanced disease may influence observed frequencies and clinical associations</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Multi-centre across India (no single-city restriction)</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer', 'publication_date_yy_mm': '2023-06'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e79.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e79.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>India regional variation (north vs south)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Reported north–south regional differences in EGFR mutation rates within India</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Review cites multiple Indian studies reporting marked regional heterogeneity in EGFR mutation prevalence, with substantially higher rates in southern India compared with northern India in some reports.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Aggregated/summary of regional Indian studies (individual study sample sizes vary across cited works)</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Indian (regional subpopulations)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Reported examples: southern Indian population incidence ≈65% vs northern Indian population ≈33% (from cited Indian studies)</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Not specified for the regional comparison in the review text</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Southern India (~65%) vs Northern India (~33%)</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Not detailed specifically for regional split beyond frequency differences</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Differences likely influenced by study selection, referral patterns, sample sizes, and testing methods across centres</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Within-country (India) north vs south variation explicitly noted</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer', 'publication_date_yy_mm': '2023-06'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e79.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e79.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Global EGFR subtype distribution</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Global distribution of EGFR mutation subtypes in NSCLC (sensitising and uncommon variants)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Review summarizes that the vast majority of sensitising EGFR mutations are exon 19 deletions and exon 21 L858R substitutions, with a minority comprising various uncommon mutations including exon 20 insertions and several point mutations.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Worldwide frequency of commonly detected EGFR mutations</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Global literature/aggregate data (not a single cohort)</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Global/mixed</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Among EGFR-mutant NSCLC: exon 19 deletions + exon 21 L858R account for ~85%–90% of mutations; uncommon mutations comprise ~10%–15%</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Exon 19 deletions and exon 21 L858R (~85%–90% combined); exon 20 insertions (4%–12%), L861Q (~3%), G719X (~2%), S768I (~1%)</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>These are the subtype breakdowns among EGFR-positive NSCLC; subtype has implications for treatment response and prognosis</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Subtype proportions may vary by geography, testing methods and patient selection</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Subtype prevalences vary by region (review notes some regional patterns elsewhere, e.g., Ex19del more common in Northern Asia, L858R more common in Southern Asia)</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer', 'publication_date_yy_mm': '2023-06'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e79.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e79.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Chinese age-subgroup (Zhang)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Age-related differences in Ex19del vs L858R prevalence in Chinese NSCLC patients</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Cited study observed that Ex19del was more common than L858R among Chinese patients younger than 50 years and described variation of subtype frequencies across age strata.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>The difference of clinical characteristics between patients with Ex19Del and those with L858R Mutation in Nonsmall cell lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Chinese NSCLC patients (Zhang et al. cohort; elsewhere in the review a Zhang study of 1271 patients is referenced for related analyses)</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Chinese</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Specific overall EGFR frequency not restated here; relative subtype finding: Ex19del more common than L858R in patients <50 years (p<0.001)</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Ex19del predominance in younger Chinese patients; relative shift to L858R in older age groups (>60 years)</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Age-stratified comparison within Chinese cohort (younger vs older age groups)</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Ex19del associated with younger age and higher likelihood of lymphatic metastasis in cited analyses</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Age-related patterns may be influenced by cohort composition and detection practices</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Within-China age-related variation described; broader geographic comparisons given elsewhere in review</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer', 'publication_date_yy_mm': '2023-06'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e79.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e79.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Sex and smoking associations (pooled/Indian)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Sex and smoking-associated differences in EGFR positivity (reported in pooled Indian data)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Pooled Indian data/meta-analysis cited in the review reports higher EGFR mutation prevalence in females and never-smokers compared with males and smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>27 epidemiology of EGFR positive adenocarcinoma NSCLC from India: A systematic review and meta-analysis</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Aggregated Indian adenocarcinoma NSCLC datasets included in the meta-analysis</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Indian</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Overall pooled prevalence 36.9% (95% CI 33.0 to 40.8); subgroup rates: females 42.2% vs males 26.5%; non-smokers 40.9% vs smokers 21.4%</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Not split by subtype in these specific sex/smoking comparisons in the review excerpt</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td>EGFR mutations substantially more frequent in never-smokers than in smokers (40.9% vs 21.4%)</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Within-India subgroup comparisons by sex and smoking status</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>EGFR positivity enriched in females and never-smokers; predominance in adenocarcinoma histology</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Potential confounders include differential referral/testing of non-smokers and females, histology distribution, and study heterogeneity</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Findings reported in pooled Indian studies; similar sex/smoking patterns described in other Asian cohorts elsewhere in the review</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer', 'publication_date_yy_mm': '2023-06'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER) <em>(Rating: 2)</em></li>
                <li>Frequency of EGFR mutations in 907 lung adenocarcinoma patients of Indian Ethnicity <em>(Rating: 2)</em></li>
                <li>Clinical and Epidemiological study of EGFR mutations and Eml4-ALK fusion genes among Indian patients with adenocarcinoma of the lung <em>(Rating: 2)</em></li>
                <li>27 epidemiology of EGFR positive adenocarcinoma NSCLC from India: A systematic review and meta-analysis <em>(Rating: 2)</em></li>
                <li>Worldwide frequency of commonly detected EGFR mutations <em>(Rating: 2)</em></li>
                <li>The difference of clinical characteristics between patients with Ex19Del and those with L858R Mutation in Nonsmall cell lung cancer <em>(Rating: 2)</em></li>
                <li>Correlation between serum CEA levels and EGFR mutations in Chinese Nonsmokers with lung adenocarcinoma <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>